Log In
Print
BCIQ
Print
Print this Print this
 

Matrix M adjuvant (Matrix-M)

  Manage Alerts
Collapse Summary General Information
Company Novavax Inc.
DescriptionVaccine adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPhase I
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant for pandemic influenza virus (H5N1), seasonal influenza, malaria, herpes simplex virus-2 (HSV-2), and anthrax
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today